MedTrace Logo

The Study of Barrett's Esophagus: What Are the Factors of Progression

NCT00586404 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 1250

Last updated 2017-05-30

No results posted yet for this study

Summary

This trial is a multi-center clinical and endoscopic outcomes project involving a single large database of patients with Barrett's Esophagus (BE). The initial goal of this project is to define the incidence and prevalence of cancer and high-grade dysplasia (HGD) in patients with BE. Thus, our hypothesis is that systematic collection of data on the natural history of BE and risk factors for progression of BE will provide useful information to develop a decision model for risk stratification and risk reduction strategies in BE.

Conditions

  • Barrett's Esophagus
  • Esophageal Neoplasms

Sponsors & Collaborators

  • TAP Pharmaceutical Products Inc.

    collaborator INDUSTRY

  • Kansas City Veteran Affairs Medical Center

    collaborator FED

  • Midwest Biomedical Research Foundation

    lead OTHER

Principal Investigators

  • Prateek Sharma, MD · Department of Veterans Affairs Medical Center of Kansas City

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2007-11-30
Primary Completion
2017-05-31
Completion
2017-05-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00586404 on ClinicalTrials.gov